Trial Details

TERMINATED
Basic Information
Clinical ID c3478
Identifier NCT01986127
Trial Title Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: Adalimumab|DRUG: placebo
Participant Information
Sponsor Sara Varea
City A Coruña
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2014-02-14
Primary Completion Date 2018-06-30
Completion Date 2018-06-30